Reviewing a 20-month run with a radiologist-to-technologist communications tool, researchers have found minor problems with image quality 10 times more common than patient callbacks for repeat imaging.

Bracco Diagnostics, Inc has been given the go ahead by the U.S. Food and Drug Administration to temporarily import Iomeron (iomeprol injection) into the U.S. market amid the ongoing iodinated contrast media shortage. 

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting. 

Healthcare deals stalled during the second quarter of 2022, but the baker’s dozen transactions recorded during the three-month period were offset by a high percentage of mega deals.

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.

For years radiology educators have been reassuring prospects, recruits and trainees that artificial intelligence can only—and will only—assist or augment radiologists. And still a nervous concern continues to come up. 

Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference.